Cochrane Abstracts
Vedolizumab for induction and maintenance of remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vedolizumab for Induction and Maintenance of Remission in Crohn's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437011/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_Crohn's_disease. Accessed 14 September 2024.
Vedolizumab for induction and maintenance of remission in Crohn's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437011/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_Crohn's_disease. Accessed September 14, 2024.
Vedolizumab for induction and maintenance of remission in Crohn's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437011/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_Crohn's_disease
Vedolizumab for Induction and Maintenance of Remission in Crohn's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 September 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437011/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_Crohn's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vedolizumab for induction and maintenance of remission in Crohn's disease
ID - 437011
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437011/all/Vedolizumab_for_induction_and_maintenance_of_remission_in_Crohn's_disease
DB - Evidence Central
DP - Unbound Medicine
ER -
